Key Pharmacy Recalls Folinic Acid Injections Due to Sterility Concerns
Key Pharmacy and Compounding Center is recalling specific lots of Folinic Acid injections because the firm cannot guarantee the products are sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in compounded drugs, which poses a significant risk of infection or serious injury, meeting the criteria for a Severe rating.
Plain-English summary
Key Pharmacy and Compounding Center is recalling Folinic Acid MDV (CALIF) 5MG/ML INJ, a prescription-only injection packaged in 5 mL and 10 mL glass multiple-dose vials. The recall involves three specific vials identified by lot numbers t02-09-2017@74, t02-17-2017@89, and t02-20-2017@72. These products were distributed nationwide in the U.S.A., as well as in Australia and Canada.
The recall was initiated due to a lack of assurance of sterility. The firm is recalling these sterile compounded drugs, which are within their expiry dates, because it cannot verify that they remain sterile. The agency has classified this recall as Class II.
Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed above. If these products are found, they should be returned to the pharmacy or the recalling firm for disposal or credit, as directed by the recall notice.
The recalled product
- Product
- FOLINIC ACID MDV (CALIF) 5MG/ML INJ, Injection, 5mg/mL, Rx only, packaged in 5 mL and10 mL glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy
- Manufacturer
- Key Pharmacy and Compounding Center
- Category
- Drug — Compounded Sterile Drug
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot # t02-09-2017@74
- Exp 5/15/2017
- t02-17-2017@89
- Exp 5/21/2017
- t02-20-2017@72
- Exp 5/22/2017.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 79 recalled by Key Pharmacy and Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 79 products in this recall →Related recalls
Same manufacturer · Key Pharmacy and Compounding Center
See all →- SevereKey Pharmacy Recalls Pyridoxal-5-Phosphate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Sterile Compounded Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighKey Pharmacy Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls 5-MTHF Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29